Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and Voriconazole

被引:4
|
作者
Martinez, Dalila Y. [1 ,2 ]
Bravo-Cossio, Fanny [3 ]
del Carmen Valdivia-Tapia, Maria [3 ]
Yhuri Carreazo, Nilton [3 ]
Cabello-Vilchez, Alfonso M. [1 ,4 ]
机构
[1] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru
[2] Hosp Cayetano Heredia, Dept Enfermedades Infecciosas Trop & Dermatol, Lima, Peru
[3] Hosp Emergencias Pediat, Lima, Peru
[4] Univ Privada Norbert Wiener, Escuela Tecnol Med Lab Clin & Anat Patol, Lima, Peru
关键词
Naegleria; Central nervous system protozoal infections; Child; Miltefosine; Voriconazole; NAEGLERIA-FOWLERI; BALAMUTHIA-MANDRILLARIS; IN-VITRO; DIAGNOSIS; INFECTION;
D O I
10.1007/s11686-022-00591-9
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The genus Naegleria consists of free-living amoebae widely distributed worldwide in soil and freshwater habitats. Primary amoebic meningoencephalitis (PAM) is an uncommon and most likely fatal disease. The incubation period is approximately 7 days. The first symptoms are headache, nasal congestion, fever, vomiting, stiff neck within 3-4 days after the first symptoms, confusion, abnormal behavior, seizures, loss of balance and body control, coma, and death. We describe the case of a child who presented with PAM due to Naegleria sp., fully recovered from the infection without apparent sequels after treatment with a regimen that included miltefosine and voriconazole.
引用
收藏
页码:1421 / 1424
页数:4
相关论文
共 30 条
  • [1] Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and Voriconazole
    Dalila Y. Martínez
    Fanny Bravo-Cossio
    María del Carmen Valdivia-Tapia
    Nilton Yhuri Carreazo
    Alfonso M. Cabello-Vilchez
    Acta Parasitologica, 2022, 67 : 1421 - 1424
  • [2] Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment
    Chao-Pellicer, Javier
    Arberas-Jimenez, Inigo
    Fuchs, Frieder
    Pinero, Jose E.
    Sifaoui, Ines
    Lorenzo-Morales, Jacob
    Scheid, Patrick
    ANTIBIOTICS-BASEL, 2023, 12 (08):
  • [3] Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case
    Cope, Jennifer R.
    Conrad, Dennis A.
    Cohen, Naiomi
    Cotilla, Manuel
    DaSilva, Alexandre
    Jackson, Jonathan
    Visvesvara, Govinda S.
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (06) : 774 - 776
  • [4] Case Report: Treatment of Granulomatous Amoebic Encephalitis with Voriconazole and Miltefosine in an Immunocompetent Soldier
    Webster, Duncan
    Umar, Imram
    Kolyvas, George
    Bilbao, Juan
    Guiot, Marie-Christine
    Duplisea, Kevin
    Qvarnstrom, Yvonne
    Visvesvara, Govinda S.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2012, 87 (04) : 715 - 718
  • [5] Therapeutic glycan-specific antibody binding mediates protection during primary amoebic meningoencephalitis
    Moseman, Annie Park
    Chen, Ching-wen
    Liang, Xiaoe
    Liao, Dongmei
    Kuraoka, Masayuki
    Moseman, E. Ashley
    INFECTION AND IMMUNITY, 2024, 92 (10)
  • [6] Successful Treatment of an Adolescent With Naegleria fowleri Primary Amebic Meningoencephalitis
    Linam, W. Matthew
    Ahmed, Mubbasheer
    Cope, Jennifer R.
    Chu, Craig
    Visvesvara, Govinda S.
    da Silva, Alexandre J.
    Qvarnstrom, Yvonne
    Green, Jerril
    PEDIATRICS, 2015, 135 (03) : E744 - E748
  • [7] Diagnosis, Clinical Course, and Treatment of Primary Amoebic Meningoencephalitis in the United States, 1937-2013
    Capewell, Linda G.
    Harris, Aaron M.
    Yoder, Jonathan S.
    Cope, Jennifer R.
    Eddy, Brittany A.
    Roy, Sharon L.
    Visvesvara, Govinda S.
    Fox, LeAnne M.
    Beach, Michael J.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2015, 4 (04) : E68 - E75
  • [8] Successful Treatment of Therapy-refractory Acanthamoeba Keratitis with Systemic Miltefosine and Topical Voriconazole
    Schwarzer, Petra
    Blaser, Frank
    Sellner, Miriam
    Rauthe, Stephan Christian
    Tandogan, Tamer
    Tappeiner, Christoph
    Goldblum, David
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (04) : 406 - 408
  • [9] The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis
    Zeniskova, Katerina
    Mach, Jan
    Arbon, Dominik
    Stursa, Jan
    Werner, Lukas
    Zoltner, Martin
    Sutak, Robert
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (02)
  • [10] Novel Chemotherapeutic Strategies in the Management of Primary Amoebic Meningoencephalitis Due to Naegleria fowleri
    Baig, Abdul M.
    Khan, Naveed A.
    CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (03) : 289 - 290